Techbio entrepreneur, advisor, and director; algorithms expert including AI for RNA drug discovery and health; Fold AI (rnafold.ai) founder and CEO; Biological AI lab (bioai.au) founder; Australian Institute of Company Directors Graduate (GAICD)

Senior Lecturer, Research Associate

Our research involves searching for new treatments and detection methods for CNS diseases, like frontotemporal dementia, amyotrophic lateral sclerosis, autism spectrum disorder and disorders involving neuroinflammation. We use techniques such as tissue culture, iPSCs, transfection, cellular assays, immunohistochemistry, radioligand binding, PCR, sequencing and western blots to find new drug targets and therapeutics for these diseases.

Postdoctoral Research Associate (MedChem Australia)

Andrew completed his PhD under the supervision of Prof. Danielle Skropeta and Prof. Haibo Yu at the University of Wollongong in 2019. Later that year, he joined Michael's research group as a Centre for Drug Discovery Innovation Postdoctoral Fellow (2019-2024). As part of this fellowship Andrew's research focussed on small molecule synthesis and computational studies for a variety of CNS drug discovery projects.  He was an Associate Lecturer in the University of Sydney's School of Chemistry (2023-2025).  Andrew is currently a Postdoctoral Fellow with MedChem Australia (2025-present).

Postdoctoral Research Associate (MedChem Australia)

Postdoctoral Research Associate (MedChem Australia)

Postdoctoral Research Fellow

Sasha majored in Pharmacology while completing her Bachelor of Medical Science at USYD. This exposure made her realise her passion for Pharmacology – specifically the drug design aspect – and led her to approach Prof Michael Kassiou with interest in an Honours project under his supervision. Her Honours project focused on drug design for targeting the oxytocin signalling pathway as an avenue for therapeutics to treat social disorders. This opportunity allowed her to experience working in a lab-based research environment with some of the most gifted people she knows. Sasha enjoyed this process immensely, thus deciding to further pursue this career path by beginning her PhD under the supervision of Dr Eryn Werry and Prof Michael Kassiou, with a focus on drug design in neurodegeneration. She completed her PhD 

Postdoctoral Research Associate

Postdoctoral Research Associate (MedChem Australia)

Postdoctoral Research Associate (MedChem Australia) 

if he ever replies to us